October 7, 2026StocksTechnology·Neutral·regulatory
Clearmind Medicine submits recommendations to FDA on future therapeutic use of non-hallucinogenic psychedelic drugs
Clearmind Medicine says it submitted recommendations to the FDA on the future therapeutic use of non-hallucinogenic psychedelic drugs.
Detected & updated continuously · Source: Nebula
Story subjects
Clearmind Medicine Inc.Food and Drug Administration